← Mereo BioPharma Group plc
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income From Continuing Operations | — | — | — | — | — | — | ($29.5m) | ($43.3m) | ($41.9m) | ($35.7m) | |
| Depreciation | — | — | — | — | — | — | $171k | $143k | $157k | $698k | |
| Amortization of Intangible Assets | — | — | — | — | — | — | $395k | $438k | $465k | — | |
| Depreciation of property, plant and equipment | $36k | $39k | $1.6m | $1.6m | $642k | $727k | — | — | — | $1.2m | |
| Amortization Cash Flow | — | — | — | — | — | — | $395k | $438k | $465k | — | |
| Amortization Of Intangibles | — | — | — | — | — | — | $395k | $438k | $465k | $486k | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $1.1m | $1.1m | $1.1m | $1.2m | |
| Deferred Income Tax Expense (Benefit) | ($5.3m) | ($8.2m) | ($1.1m) | ($10.4m) | ($2.8m) | $1.5m | $0 | $0 | — | — | |
| Share-based Payment Arrangement, Noncash Expense | — | — | — | — | — | — | $4.9m | $7.4m | $7.6m | $6.9m | |
| Adjustments For Share-Based Payments | $3.7m | $2.2m | $1.6m | $1.6m | $3.3m | $3.9m | — | — | — | — | |
| Share-based payments expense | $3.7m | $2.2m | $1.6m | $1.6m | $3.3m | $3.9m | — | — | — | — | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | — | ($10k) | $0 | $300k | — | |
| Changes in operating assets and liabilities: | |||||||||||
| Change In Working Capital | — | — | — | — | — | — | ($1.6m) | ($369k) | ($3.2m) | ($528k) | |
| Decrease/(increase) in receivables and prepayments | ($840k) | $804k | ($936k) | $141k | ($589k) | $695k | — | — | — | — | |
| Change In Receivables | — | — | — | — | — | — | $456k | ($1.6m) | $1.4m | $349k | |
| Increase (Decrease) in Accounts Payable | — | — | — | — | — | — | ($1.3m) | $146k | ($1.4m) | $217k | |
| Increase/(decrease) in trade and other payables and accruals | $3.9m | $1.6m | ($6.7m) | ($3.6m) | ($1.3m) | $1.1m | — | — | — | — | |
| Change In Payables And Accrued Expense | — | — | — | — | — | — | ($2.0m) | ($1.0m) | ($3.8m) | $217k | |
| Change In Accrued Expense | — | — | — | — | — | — | ($710k) | ($1.2m) | ($2.4m) | ($775k) | |
| Increase in provisions and other liabilities | — | ($1.0m) | ($517k) | $162k | $1.4m | $211k | — | — | — | — | |
| Change In Other Current Liabilities | — | — | — | — | — | — | ($578k) | ($654k) | ($743k) | ($774k) | |
| Net Cash Provided by (Used in) Operating Activities | ($32.1m) |
($23.1m)
+28.03%
|
($45.9m)
-98.50%
|
($28.3m)
+38.30%
|
($5.2m)
+81.51%
|
($38.8m)
-640.98%
|
($21.1m)
+45.56%
|
($32.8m)
-55.38%
|
($31.0m)
+5.67%
|
($27.0m)
+12.97%
|
|
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | ($16k) | ($36k) | ($21k) | ($16k) | ($535k) | ($10k) | $0 | ($699k) | $20k | ($300k) | |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | — | $2k | — | — | — | — | — | — | — | — | |
| Net Other Investing Changes | — | — | — | — | — | ($814k) | — | — | $300k | $300k | |
| Net cash flows (used in)/from investing activities | ($3.7m) | $252k | $43.3m | $1.5m | ($421k) | $1.5m | — | — | — | — | |
| Net Cash Provided by (Used in) Investing Activities | — | — | — | — | — | — | ($419k) | ($699k) | ($20k) | $0 | |
| Cash flows from financing activities: | |||||||||||
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | — | — | — | $0 | — | — | |
| Proceeds From Borrowings Classified As Financing Activities | $20.0m | $455k | — | $44.4m | — | — | — | — | — | — | |
| Repayments Of Borrowings Classified As Financing Activities | — | — | — | $19.8m | — | — | — | — | — | — | |
| Transaction costs relates to loans and borrowings | — | ($921k) | $0 | ($81k) | — | — | — | — | — | — | |
| Issuance Of Debt | — | — | — | — | $0 | $0 | — | — | — | $0 | |
| Long Term Debt Issuance | — | — | — | — | $0 | $0 | — | — | — | $0 | |
| Net Issuance Payments Of Debt | — | — | — | — | ($934k) | ($1.1m) | ($3.2m) | $0 | — | $0 | |
| Net Long Term Debt Issuance | — | — | — | — | ($934k) | ($1.1m) | ($3.2m) | $0 | — | $0 | |
| Long Term Debt Payments | — | — | — | — | ($934k) | ($1.1m) | ($3.2m) | $0 | — | $0 | |
| Repayment Of Debt | — | — | — | — | ($934k) | ($1.1m) | ($3.2m) | $0 | — | $0 | |
| Issuance Of Capital Stock | — | — | — | — | — | $0 | $11.6m | $47.0m | $39k | $39k | |
| Proceeds from Issuance of Common Stock | — | — | — | — | — | — | $11.6m | $47.0m | $39k | $39k | |
| Common Stock Issuance | — | — | — | — | — | $0 | $11.6m | $47.0m | $39k | $39k | |
| Cash Dividends Paid | — | — | — | — | $0 | $0 | — | — | — | $0 | |
| Net Other Financing Charges | — | — | — | — | — | — | ($444k) | ($853k) | ($199k) | ($199k) | |
| Net cash flows (used in)/from financing activities | $33.7m |
($2.1m)
-106.15%
|
($5.7m)
-175.18%
|
$34.7m
+708.35%
|
$77.7m
+123.54%
|
($784k)
-101.01%
|
— | — | — | — | |
| Net Cash Provided by (Used in) Financing Activities | — | — | — | — | — | — | $8.0m |
$46.1m
+478.79%
|
$327k
-99.29%
|
($95k)
-129.05%
|
|
| Net (decrease)/increase in cash and cash equivalents | ($2.1m) | ($25.0m) | ($8.3m) | $7.9m | $72.0m | ($38.1m) | — | — | — | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | — | — | — | — | $12.4m | — | $35.4m | |
| Beginning Cash Position | — | — | — | — | — | — | $68.2m | $57.4m | $69.8m | $62.5m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | $2.8m | ($233k) | $1.9m | $789k | |
| Effect of exchange rate changes | ($1.4m) | ($41k) | ($349k) | $253k | ($1.2m) | $145k | $2.8m | ($233k) | $1.9m | $789k | |
| Additional Supplementary Disclosures | |||||||||||
| Additional Supplementary Disclosures | |||||||||||
| Income Tax Expense (Benefit) | — | — | — | — | — | — | ($532k) | $0 | $0 | — | |
| Additional Financial Items | |||||||||||
| Adjustments For Decrease Increase In Trade Account Receivable | ($840k) | $804k | — | — | — | — | — | — | — | — | |
| Adjustments For Finance Costs | $1.1m | $1.9m | $3.7m | $6.2m | $3.8m | $2.9m | — | — | — | — | |
| Adjustments For Increase Decrease In Trade Account Payable | $3.9m | $1.6m | — | — | — | — | — | — | — | — | |
| Adjustments For Unrealised Foreign Exchange Losses Gains | $1.4m | $44k | ($483k) | $1.8m | $954k | ($2.1m) | — | — | — | — | |
| Foreign Currency Transaction Gain (Loss), before Tax | — | — | — | — | — | — | ($2.3m) | $1.2m | ($6.3m) | — | |
| General and Administrative Expense | — | — | — | — | — | — | $18.4m | $26.4m | $23.0m | — | |
| Interest Received Classified As Operating Activities | ($827k) | ($307k) | — | — | — | — | — | — | — | — | |
| Investment Income, Interest | — | — | — | — | — | — | $2.1m | $3.0m | $2.2m | — | |
| Operating Costs and Expenses | — | — | — | — | — | — | $700k | $700k | $700k | — | |
| Payments Of Lease Liabilities Classified As Financing Activities | — | — | $2.2m | $2.1m | $692k | $937k | — | — | — | — | |
| Payments To Acquire Or Redeem Entitys Shares | — | $307k | $998k | — | — | — | — | — | — | — | |
| Proceeds From Issuing Shares | $15.0m | $273k | — | $20.1m | $78.5m | — | — | — | — | — | |
| Purchase Of Intangible Assets Classified As Investing Activities | $2.3m | — | — | — | — | — | — | — | — | — | |
| (Loss)/profit before tax | ($47.0m) | ($37.3m) | ($41.1m) | ($166.4m) | $14.2m | ($36.1m) | — | — | — | — | |
| Net foreign exchange (gain)/loss | $1.4m | $44k | ($483k) | $1.8m | $954k | ($2.1m) | — | — | — | — | |
| Finance income | — | ($307k) | ($377k) | ($44k) | ($1k) | ($696k) | — | — | — | — | |
| Finance costs | $1.1m | $1.9m | $3.7m | $6.2m | $3.8m | $2.9m | — | — | — | — | |
| Other non-cash movements | — | — | — | — | $156k | $647k | — | — | — | — | |
| Fair value remeasurement on warrants | — | ($716k) | ($875k) | $109.8m | ($40.0m) | ($7.8m) | — | — | — | — | |
| (Gain)/loss on disposal of intangible assets | — | — | — | $10.9m | ($113k) | — | — | — | — | — | |
| Taxation | $5.3m | $8.2m | $1.1m | $10.4m | $2.8m | ($1.5m) | — | — | — | — | |
| Acquisition of subsidiary | — | — | $10.1m | ($354k) | — | — | — | — | — | — | |
| Proceeds from intangible assets (net of transaction costs) | — | — | — | $1.8m | $113k | $1.5m | — | — | — | — | |
| Interest earned | $1.1m | $286k | $377k | $44k | $1k | $696k | — | — | — | — | |
| Proceeds from issuance of ordinary shares | $15.0m | $273k | $0 | $20.1m | $78.5m | — | — | — | — | — | |
| Transaction costs on issuance of shares | ($730k) | ($8k) | ($761k) | ($1.3m) | ($234k) | — | — | — | — | — | |
| Proceeds from exercise of employee share options | — | — | $0 | — | $46k | — | — | — | — | — | |
| Transaction costs on issuance of convertible loan notes | ($200k) | ($921k) | — | ($3.6m) | — | — | — | — | — | — | |
| [Proceeds from TAP agreement] | — | $78k | — | — | — | $153k | — | — | — | — | |
| Payment of lease liabilities | — | — | ($2.2m) | ($2.1m) | ($692k) | ($937k) | — | — | — | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | $8.0m | $46.1m | $327k | ($95k) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | ($419k) | ($699k) | ($20k) | $0 | |
| Change In Account Payable | — | — | — | — | — | — | ($1.3m) | $146k | ($1.4m) | $217k | |
| Change In Payable | — | — | — | — | — | — | ($1.3m) | $146k | ($1.4m) | $217k | |
| Change In Prepaid Assets | — | — | — | — | — | — | $502k | $3.0m | ($84k) | $455k | |
| Changes In Cash | — | — | — | — | — | — | ($13.6m) | $12.6m | ($30.7m) | ($27.0m) | |
| End Cash Position | — | — | — | — | — | — | $57.4m | $69.8m | $41.0m | $35.4m | |
| Financing Cash Flow | — | — | — | — | — | — | $8.0m |
$46.1m
+478.79%
|
$327k
-99.29%
|
($95k)
-129.05%
|
|
| Free Cash Flow | — | — | — | — | — | — | ($21.6m) | ($33.5m) | ($31.3m) | ($27.3m) | |
| Gain Loss On Investment Securities | — | — | — | — | — | — | ($245k) | $419k | ($909k) | ($510k) | |
| Gain Loss On Sale Of PPE | — | — | — | — | ($153k) | $0 | — | — | — | $0 | |
| Interest Received CFI | — | — | — | — | $1k | $842k | — | — | — | $991k | |
| Investing Cash Flow | — | — | — | — | — | — | ($419k) | ($699k) | ($20k) | $0 | |
| Net Business Purchase And Sale | — | — | — | — | $0 | $0 | — | — | — | $0 | |
| Net Foreign Currency Exchange Gain Loss | — | — | — | — | — | — | $2.3m | ($1.2m) | $6.3m | $2.0m | |
| Net Intangibles Purchase And Sale | — | — | — | — | — | — | ($419k) | ($699k) | ($300k) | ($300k) | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | $0 | $0 | ($20k) | $0 | |
| Operating Gains Losses | — | — | — | — | — | — | $2.1m | ($791k) | $5.4m | $1.4m | |
| Other Non Cash Items | — | — | — | — | — | — | $1.8m | $3.1m | ($72k) | — | |
| Proceeds From Stock Option Exercised | — | — | — | — | $62k | $0 | — | $0 | $487k | $0 | |
| Provisionand Write Offof Assets | — | — | — | — | $1.9m | $255k | — | — | — | $1.0m | |
| Purchase Of Business | — | — | — | — | $0 | $0 | — | — | — | $0 | |
| Purchase Of Intangibles | — | — | — | — | — | — | ($419k) | ($699k) | ($300k) | ($300k) | |
| Purchase Of PPE | — | — | — | — | — | — | $0 | $0 | ($20k) | ($300k) | |
| Sale Of Intangibles | — | — | — | — | $153k | $1.8m | — | — | — | $0 | |
| Stock Based Compensation | — | — | — | — | — | — | $4.9m | $7.4m | $7.6m | $6.9m | |
| Gain (Loss) on Derivative Instruments, Net, Pretax | — | — | — | — | — | — | $245k | ($419k) | $805k | — | |
| Cash and cash equivalents at January 1 | $50.0m | $25.0m | $16.3m | $23.5m | $94.3m | $56.3m | — | — | — | — | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | ($10.8m) | $12.6m | ($30.7m) | — | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | ($327k) | ($1.6m) | ($1.7m) | ($2.9m) | $0 | $0 | $884k | $21k | $29k | — | |
| Interest Paid Classified As Financing Activities | $327k | $1.6m | $1.7m | $2.9m | $0 | $0 | — | — | — | — | |
| Income Taxes Paid, Net | — | — | — | — | — | — | ($1.3m) | $0 | — | — |